Georgios Paterakis
Overview
Explore the profile of Georgios Paterakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karela C, Tsagarakis N, Oudatzis G, Xanthopoulos V, Milaiou M, Nikolaou S, et al.
Int J Lab Hematol
. 2024 Oct;
47(2):228-235.
PMID: 39478200
Introduction: Fluorescently labeled aerolysin (FLAER) is widely used for the identification of paroxysmal nocturnal hemoglobinuria (PNH) clones in peripheral blood (PB) samples. However, there are only a few reports on...
2.
Ampatzidou M, Papadhimitriou S, Paisiou A, Paterakis G, Tzanoudaki M, Papadakis V, et al.
Diagnostics (Basel)
. 2023 May;
13(9).
PMID: 37174980
One of the most frequent genes affected in pediatric ALL is the CDKN2A/2B gene, acting as a secondary cooperating event and playing an important role in cell-cycle regulation and chemosensitivity....
3.
Tsagarakis N, Androutsos G, Chaliori I, Chaniotaki S, Paterakis G, Kritikou-Griva E
Int J Lab Hematol
. 2022 Sep;
44(6):1027-1028.
PMID: 36111513
No abstract available.
4.
Maurer-Granofszky M, Schumich A, Buldini B, Gaipa G, Kappelmayer J, Mejstrikova E, et al.
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885257
Monitoring of minimal residual disease (MRD) by flow cytometry (FCM) is a powerful prognostic tool for predicting outcomes in acute lymphoblastic leukemia (ALL). To apply FCM-MRD in large, collaborative trials,...
5.
Kritikou-Griva E, Chaliori I, Tsagarakis N, Androutsos G, Chaniotaki S, Paterakis G
Blood Res
. 2021 Aug;
56(3):126.
PMID: 34349042
No abstract available.
6.
Ampatzidou M, Florentin L, Papadakis V, Paterakis G, Tzanoudaki M, Bouzarelou D, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34209196
We present our data of a novel proposed CNA-profile risk-index, applied on a Greek ALLIC-BFM-treated cohort, aiming at further refining genomic risk-stratification. Eighty-five of 227 consecutively treated ALL patients were...
7.
Tsikandilakis M, Leong M, Yu Z, Paterakis G, Bali P, Derrfuss J, et al.
Psychol Res
. 2021 Jan;
86(1):37-65.
PMID: 33484351
Psychological theory and research suggest that religious individuals could have differences in the appraisal of immoral behaviours and cognitions compared to non-religious individuals. This effect could occur due to adherence...
8.
Tsagarakis N, Papadhimitriou S, Pavlidis D, Liapis K, Gortzolidis G, Kostopoulos I, et al.
Cytometry B Clin Cytom
. 2020 Jun;
98(5):412-420.
PMID: 32497402
Background: There are no immunophenotypic guidelines for the investigation of MYC-rearranged lymphomas. We aimed to identify simple immunophenotypic features that would help to differentiate between MYC-rearranged lymphomas and guide cytogenetic...
9.
Oudatzis G, Tsagarakis N, Paterakis G, Vasileiou P, Xenou E, Maraki P, et al.
Int J Lab Hematol
. 2020 May;
42(5):565-572.
PMID: 32426940
Introduction: Venous blood (VB) sampling for complete blood count (CBC) via venipuncture is the basic method for the daily evaluation of hematological patients. However, several issues during this process, such...
10.
Tsagarakis N, Paterakis G
Curr Oncol Rep
. 2020 May;
22(6):55.
PMID: 32415624
Purpose Of Review: The purpose of this review was to summarize the clinical, diagnostic, and therapeutic features of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Recent Findings: Several case reports and...